Anila Kanna
Neurology with Special Qualifications in Child Neurology · Covington, LANPI 1538515200
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 131 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by UCB, Inc. at 28.0% of the total. 2024 is the largest year on record at $1,158, more than ten times the $74 reported in 2020. That places this record below the midpoint for neurology with special qualifications in child neurology clinicians in LA, where the typical reported total is $5,367.
Across 131 payments — averaging $22.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$839
- SK Life Science, Inc.$655
- Neurelis, Inc.$411
- AstraZeneca$209
- GRT US Holding, Inc.$123
- Teva Pharmaceuticals USA, Inc.$116
- plus $646 from 17 others
What the payments were for
- Food & beverage$2,999100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 40 | $839 |
| SK Life Science, Inc. | 23 | $655 |
| Neurelis, Inc. | 17 | $411 |
| AstraZeneca(2 entities) | 13 | $209 |
| GRT US Holding, Inc. | 1 | $123 |
| Teva Pharmaceuticals USA, Inc. | 7 | $116 |
| Biogen | 6 | $110 |
| Octapharma USA, Inc. | 1 | $98 |
| Genentech USA, Inc. | 4 | $71 |
| Jazz Pharmaceuticals Inc. | 3 | $63 |
| Amgen(2 entities) | 2 | $42 |
| Lundbeck LLC | 2 | $41 |
| Argenx US, Inc. | 2 | $30 |
| Acorda Therapeutics, Inc | 1 | $26 |
| AbbVie | 1 | $24 |
| Pyros Pharmaceuticals, Inc. | 1 | $21 |
| PTC Therapeutics, Inc. | 1 | $21 |
| Ipsen Biopharmaceuticals, Inc | 1 | $21 |
| Immedica Pharma US, Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $17 |
| Kyowa Kirin, Inc. | 1 | $16 |
| Aquestive Therapeutics, Inc. | 1 | $15 |
| Biomarin Pharmaceutical Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,999 in reported general payments places this provider in the 40th percentile of 30 neurology with special qualifications in child neurology providers in Louisiana.
See all neurology with special qualifications in child neurology providers in Louisiana →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxcarbazepine | 16 | $408 |
| Lamotrigine | 11 | $206 |
| Gabapentin | 16 | $165 |
Paid to pharmacies, not to this prescriber.
Other neurology with special qualifications in child neurology in Covington
- John FlattCovington$14K
- Aristotel Pena-MichesMonroe$207K
- Ann Henderson TiltonNew Orleans$119K
- Cresha DavisWest Monroe$73K
- Joaquin WongNew Orleans$28K
- Allison ConraveyNew Orleans$15K
- Stephen NelsonMetarie$11K
- Shannon McGuireBaton Rouge$10K
- David HoughtonNew Orleans$9K
- Jeremy TolerNew Orleans$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.